The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The indications, efficacy and adverse events of rituximab in a large cohort of patients with juvenile-onset SLE
Authors
Keywords
-
Journal
LUPUS
Volume 24, Issue 1, Pages 10-17
Publisher
SAGE Publications
Online
2014-08-13
DOI
10.1177/0961203314547793
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- B-cell-targeted therapies in systemic lupus erythematosus and ANCA-associated vasculitis: current progress
- (2013) Md Yuzaiful Md Yusof et al. Expert Review of Clinical Immunology
- Children and adolescents with SLE: not just little adults
- (2013) TA Morgan et al. LUPUS
- Lupus nephritis: a 15‐year multi‐centre experience in the UK
- (2013) M Hui et al. LUPUS
- Clinical outcomes and safety of rituximab treatment for patients with systemic lupus erythematosus (SLE) – results from a nationwide cohort in Germany (GRAID)
- (2013) M Witt et al. LUPUS
- Disease activity, severity, and damage in the UK juvenile-onset systemic lupus erythematosus cohort
- (2012) Louise Watson et al. ARTHRITIS AND RHEUMATISM
- Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study
- (2012) Brad H. Rovin et al. ARTHRITIS AND RHEUMATISM
- Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience
- (2012) Meryem Can et al. CLINICAL RHEUMATOLOGY
- Multicenter longitudinal study of B-lymphocyte depletion in refractory systemic lupus erythematosus: the LESIMAB study
- (2012) A Fernández-Nebro et al. LUPUS
- Efficacy of rituximab in 164 patients with biopsy-proven lupus nephritis: Pooled data from European cohorts
- (2011) Cándido Díaz-Lagares et al. AUTOIMMUNITY REVIEWS
- Rituximab infusion-related adverse event rates are lower in patients with systemic lupus erythematosus than in those with rheumatoid arthritis
- (2011) F. Conti et al. RHEUMATOLOGY
- Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis
- (2010) Stephen D Marks et al. ACTA PAEDIATRICA
- Safety and efficacy of rituximab in systemic lupus erythematosus: Results from 136 patients from the French autoimmunity and rituximab registry
- (2010) Benjamin Terrier et al. ARTHRITIS AND RHEUMATISM
- Off-label use of rituximab in systemic lupus erythematosus: a systematic review
- (2010) Eleanor Murray et al. CLINICAL RHEUMATOLOGY
- Phenotypic Changes of Lymphocytes in Patients with Systemic Lupus Erythematosus Who Are in Longterm Remission After B Cell Depletion Therapy with Rituximab
- (2010) S. IWATA et al. JOURNAL OF RHEUMATOLOGY
- Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: The randomized, double-blind, phase ii/iii systemic lupus erythematosus evaluation of rituximab trial
- (2009) Joan T. Merrill et al. ARTHRITIS AND RHEUMATISM
- Off-label use of rituximab in a tertiary Queensland hospital
- (2009) S. J. Butterly et al. INTERNAL MEDICINE JOURNAL
- Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus
- (2008) Hermine I. Brunner et al. ARTHRITIS AND RHEUMATISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started